Bionanocomposite systems based on montmorillonite and biopolymers for the controlled release of olanzapine

dc.contributor.authorPergher, Sibele Berenice Castellã
dc.contributor.authorOliveira, Artur S.
dc.contributor.authorAlcântara, Ana C.S.
dc.date.accessioned2020-07-13T17:16:01Z
dc.date.available2020-07-13T17:16:01Z
dc.date.issued2017-06-01
dc.description.resumoOlanzapine (OLZ) is a drug that is used in the treatment of schizophrenia and other psychoses, and it belongs to the thienobenzodiazepine class. The OLZ molecule has low solubility decreasing bioavailability, but has high permeability in membrane biological being classified as a Class II drug substance according to the Biopharmaceutics Classification System. It was reported many side effects of administering OLZ orally. So, in order to increase the bioavailability of drug and possibly reducing some of side effects, this paper proposes a new material able to controllably release the drug in the body. To control the dissolution rate, this work proposes a system that incorporates the drug into montmorillonite (MMT) dispersed in a mixture of alginate (ALG) and xanthan gum (XG) biopolymers. The proposed hybrids and bionanocomposites were characterized by several physicochemical techniques, including XRD, IR-ATR, TG DTA, SEM-EDS and HPLC. The characterization data confirmed the intercalation of the OLZ into the MMT by the ion exchange process, as well as the interaction of the MMT-OLZ with the biopolymers. The release test, conducted under various pH conditions, showed that the proposed system exhibited a more controlled drug release than commercial tablets, indicating that the ALG-XG/MMT-OLZ bionanocomposite can act as a controlled release system for OLZpt_BR
dc.identifier.citationOLIVEIRA, Artur S.; ALCÂNTARA, Ana C.S.; PERGHER, Sibele Berenice Castellã. Bionanocomposite systems based on montmorillonite and biopolymers for the controlled release of olanzapine. Materials Science And Engineering: C, [s.l.], v. 75, p. 1250-1258, jun. 2017. ISSN 0928-4931. Disponível em https://www.sciencedirect.com/science/article/abs/pii/S092849311631685X?via%3Dihub. Acesso em: 13 jul. 2020. http://dx.doi.org/10.1016/j.msec.2017.03.044pt_BR
dc.identifier.doi10.1016/j.msec.2017.03.044
dc.identifier.issn0928-4931
dc.identifier.urihttps://repositorio.ufrn.br/jspui/handle/123456789/29580
dc.languageenpt_BR
dc.publisherElsevierpt_BR
dc.rightsAttribution 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/br/*
dc.subjectBionanocompositept_BR
dc.subjectHybridpt_BR
dc.subjectMontmorillonitept_BR
dc.subjectXanthan gumpt_BR
dc.subjectAlginatept_BR
dc.subjectOlanzapinept_BR
dc.subjectDrug deliverypt_BR
dc.titleBionanocomposite systems based on montmorillonite and biopolymers for the controlled release of olanzapinept_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
BionanocompositeSystems_Pergher_2017.pdf
Tamanho:
1.59 MB
Formato:
Adobe Portable Document Format
Carregando...
Imagem de Miniatura
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar